The Raf/MEK/ERK pathway contributes to inducing growth factors involved in cell proliferation, as well as influencing apoptotic pathways, allowing cells to respond with the aggressive growth behavior characteristic of RCC [12]. Here, MAP2K7 is linked to renal cell carcinoma.